A loss of capture marks the point at which the delivered stimulus no longer reliably depolarizes cardiac tissue, while restored capture identifies a setting that produces consistent cardiac activation. Comparing these points lets clinicians judge whether the programmed output is sufficient for dependable pacing rather than relying on an isolated heartbeat. This distinction is central to interpreting the measurement.
Pacing threshold measurement can involve reducing stimulus amplitude or pulse width to lower the delivered pacing stimulus. Either adjustment helps reveal when capture disappears and where it returns consistently. Recording which output parameter was changed matters because the measured threshold is tied to the specific pacing condition used during the assessment.
Clinicians program above the lowest setting that consistently produces capture, creating an appropriate safety margin for dependable pacing. At the same time, avoiding unnecessarily high output can help limit battery use. The measurement therefore connects a physiologic finding with two practical programming goals: maintaining reliable cardiac activation and preserving device resources.
A changed pacing threshold may provide information about lead position or lead function, as well as changes in myocardial responsiveness. For that reason, the result is not interpreted only as a programming number. Its relationship to earlier measurements can help clinicians evaluate whether device performance or the tissue response has changed.
During testing, clinicians adjust the pacing output, typically by reducing stimulus amplitude or pulse width, while observing whether cardiac capture continues. They identify the point at which capture is lost, then increase or otherwise restore the stimulus until capture is reliable again. The lowest consistently effective setting becomes the basis for programming decisions and safety-margin selection.
Serial measurements provide a way to compare pacing performance over time rather than relying on a single assessment. During implantation and later follow-up, clinicians can use changing thresholds to evaluate lead performance and myocardial responsiveness. This ongoing comparison supports recognition of clinically relevant changes and helps determine whether device programming remains appropriate.